Strengthening Collaboration Between Tuberculosis Control Programs and Affiliated Partners in the United States.
Forecast
Centers for Disease Control - NCHHSTP plans to offer grants to nonprofits, state and local governments and tribes. It expects to make one award worth $1.6 million in total. It is a forecast: the notice is expected around March 22, 2027, with applications due around May 21, 2027.
From the official notice on Grants.gov, last changed September 25, 2026. Checked October 31, 2026.
- Award ceilingnot stated
- Award floornot stated
- Expected awards1
- Total funding$1.6 million
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Forecast posted | September 25, 2026 |
|---|---|
| Expected posting | March 22, 2027 |
| Expected deadline | May 21, 2027 |
| Expected award date | August 30, 2027 |
Add the deadline to your calendar
Who can apply
This opportunity is open to nonprofits, state and local governments and tribes.
- State governments
- County governments
- Native American tribal governments (Federally recognized)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Territorial governments or their bona field agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands and the Republic of Palau.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The Centers for Disease Control and Prevention announces the availability of funding to support one recipient to build on the work under the previous notice of funding opportunity (CDC-RFA-PS22-2205) by strengthening collaboration and relationships with TB control programs, TB controllers, and affiliated partners in the United States. These partners include, but are not limited to, national TB control programs, other federal agencies, academia, businesses, community-based organizations, faith-based organizations, advisory boards, committees, and other entities with an interest in working with key partners in the field to advance CDC Division of Tuberculosis Elimination's mission to promote health and quality of life by preventing, controlling, and eventually eliminating TB in the United States.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Martha Boisseau, mrb0@cdc.gov, 770-488-6261.
Questions people ask
Who can apply for Strengthening Collaboration Between Tuberculosis Control Programs and Affiliated Partners in the United States.?
Centers for Disease Control - NCHHSTP accepts applications from nonprofits, state and local governments and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Strengthening Collaboration Between Tuberculosis Control Programs and Affiliated Partners in the United States.?
Expected deadline May 21, 2027. Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
About $1.6 million in total for one award.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience